EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Trained Immunity and Cardiovascular Risk: An Immunological Perspective

Katherine A Boden, Jason Chai, Tafadzwa T J Kufazvinei, Robin P Choudhury iD

Immunological Reviews · 2026-01 · 337 (1)

DOI: 10.1111/imr.70095 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 05.01.2026. Verfasst von Katherine A Boden und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Immunity, Innate, Cardiovascular Diseases, Immunologic Memory, Atherosclerosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Kusuma Trust UK, BHF-MRC Centre of Research Excellence in Advanced Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic inflammation is a key driver of atherogenesis and its complications. While anti‐inflammatory therapies targeting pathways such as IL‐1β and IL‐6 have shown promise in established atherosclerotic cardiovascular disease (ASCVD), potential systemic effects raise concerns about immune suppression and infection, underscoring the need for more precise immunomodulatory approaches. Trained immunity—a form of innate immune memory—has emerged as a potential contributor linking ASCVD risk factors to chronic inflammation and disease progression. In this review, we discuss the evidence for trained immunity in ASCVD, its induction by several known risk factors (e.g., hyperglycaemia, hypercholesterolemia, diet, chronic stress, inflammatory diseases, and infection), and its potential role in sustaining vascular inflammation. Advancing our understanding of the metabolic and epigenetic mechanisms underlying trained immunity, as well as defining shared and cumulative effects across risk factors, will be critical to guide the development of next‐generation targeted therapies for ASCVD prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateCardiovascular DiseasesImmunologic MemoryAtherosclerosisHumansAnimalsRisk FactorsInflammationHeart Disease Risk FactorsTrained Immunity

Stichwörter der Autor:innen

cardiovascular diseaseinflammationtrained immunity

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

ORCID-Profile: Robin P Choudhury

Förderung

  • Novo Nordisk Fonden
  • Kusuma Trust UK
  • BHF-MRC Centre of Research Excellence in Advanced Therapeutics

Zitieren

APA

Boden, K. A., Chai, J., Kufazvinei, T. T. J., & Choudhury, R. P. (2026). Trained Immunity and Cardiovascular Risk: An Immunological Perspective. Immunological Reviews, 337(1). https://doi.org/10.1111/imr.70095

Vancouver

Boden KA, Chai J, Kufazvinei TTJ, Choudhury RP. Trained Immunity and Cardiovascular Risk: An Immunological Perspective. Immunological Reviews. 2026;337(1). doi:10.1111/imr.70095

BibTeX
@article{Boden2026,
  author = {Boden, Katherine A and Chai, Jason and Kufazvinei, Tafadzwa T J and Choudhury, Robin P},
  title = {Trained Immunity and Cardiovascular Risk: An Immunological Perspective},
  journal = {Immunological Reviews},
  year = {2026},
  volume = {337},
  number = {1},
  doi = {10.1111/imr.70095}
}
Kostenlos starten →